GlaxoSmithKline: all 4,196 studies
Page 25 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in PhaseTerminatedNCT02258607Phase 1
- Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy VolunteersCompletedNCT02257398Phase 1
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female VolunteersCompletedNCT02257359Phase 1
- Relative Bioavailability Study of Candesartan Cilexetil Under Fasting ConditionsCompletedNCT02254447Phase 1
- A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting ConditionsCompletedNCT02254434Phase 1
- Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT02244489Phase 1
- Study on PharmacokineticsCompletedNCT02234882Phase 1
- GSK1278863 Effects on Eccentric Exercise-Induced Muscle DamageCompletedNCT02231190Phase 1
- Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes MellitusWithdrawnNCT02229240Phase 3
- GSK2190915A - Bioavailability StudyCompletedNCT02224521Phase 1
- A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® InhalerWithdrawnNCT02218762Phase 1
- Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® PresentationCompletedNCT02218723Phase 1
- A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of EpelsibanTerminatedNCT02213029Phase 1
- Helium-3 MRI Imaging Study in COPDCompletedNCT02207452Phase 1
- Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT02206763Phase 1
- Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.CompletedNCT02206711Phase 1
- A Single Oral Escalating Dose Study of GSK2140944 in Healthy VolunteersCompletedNCT02202187Phase 1
- A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting ConditionsCompletedNCT02201316Phase 1
- Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface ExpressionCompletedNCT02201303Phase 1
- Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac SodiumCompletedNCT02201238Phase 1
- A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children.CompletedNCT02201225Phase 1
- To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With AsthmaCompletedNCT02195284Phase 4
- A Safety Study to Investigate the Skin Sensitization Potential of MFC51123CompletedNCT02192203Phase 1
- Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy VolunteersCompletedNCT02185300Phase 1
- A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine TetraphosphateCompletedNCT02184637Phase 1
- Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted StatesCompletedNCT02184585Phase 1
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of AgeWithdrawnNCT02177734Phase 1
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult SubjectsCompletedNCT02169583Phase 1
- A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol GelCompletedNCT02169154Phase 1
- Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529CompletedNCT02164045Phase 1
- Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female SubjectsCompletedNCT02159131Phase 1
- Study of Combined Oral Contraceptive Effects in Female SubjectsCompletedNCT02157467Phase 1
- Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™CompletedNCT02153333
- Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult VolunteersCompletedNCT02153320Phase 1
- Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.WithdrawnNCT02141230Not applicable
- Drug-drug Interaction (DDI) RifabutinCompletedNCT02138084Phase 1
- ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With AsthmaCompletedNCT02135718
- Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)WithdrawnNCT02135666Phase 4
- China HVT Safety, PK, PDCompletedNCT02135640Phase 1
- Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy VolunteersWithdrawnNCT02130661Phase 1
- Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®WithdrawnNCT02124785Phase 4
- Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in MexicoCompletedNCT02112890
- A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of LabourCompletedNCT02106000
- Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary StudyWithdrawnNCT02100618Phase 3
- Relative Bioavailability Study With BMS-955176CompletedNCT02095886Phase 1
- A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323CompletedNCT02094924Phase 1
- Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult MalesCompletedNCT02094781Phase 1
- Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult SubjectsCompletedNCT02082808Phase 1
- Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and MidazolamCompletedNCT02082665Phase 1
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 YearsWithdrawnNCT02082639Phase 3
- A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in GermanyCompletedNCT02076386
- Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles ComparisonCompletedNCT02076269Phase 1
- Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting ConditionsCompletedNCT02075619Phase 1
- A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' AssaysCompletedNCT02072525Phase 4
- Drug Use Investigation for Arepanrix® (H1N1)CompletedNCT02069496
- A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid TumorsCompletedNCT02065063Phase 1
- Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in CombinationCompletedNCT02064504Phase 1
- The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mgCompletedNCT02064465Phase 1
- Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult SubjectsCompletedNCT02064374Phase 1
- DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)CompletedNCT02063360Phase 1
- A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult SubjectsCompletedNCT02059031Phase 1
- A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing PopulationCompletedNCT02058654Phase 1
- Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02058641Phase 1
- Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) PatientsCompletedNCT02058602Phase 1
- Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed StateCompletedNCT02058576Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy SubjectsTerminatedNCT02058407Phase 1
- Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted StateCompletedNCT02052713Phase 1
- A Validation and Dosimetry Study of GSK2634673F PET LigandTerminatedNCT02052297Phase 1
- A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and LymphomasCompletedNCT02048488Phase 1/2
- A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus SpacerCompletedNCT02045953Phase 1
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat DosesCompletedNCT02045940Phase 1
- Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy SubjectsCompletedNCT02045849Phase 1
- Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of AfuresertibCompletedNCT02040480Phase 1
- PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011CompletedNCT02039960
- A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung CancerWithdrawnNCT02034097Phase 2
- Pharmacokinetic (PK) Study of GSK933776 in Healthy VolunteersCompletedNCT02033668Phase 1
- Study to Evaluate the Effect of GSK1265744 on Cardiac ConductionCompletedNCT02027454Phase 1
- Post Marketing Surveillance for Contac Bien Z in JapanCompletedNCT02020902
- Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United StatesCompletedNCT02019732
- A Methodology Study to Assess Muscle Damage After Eccentric ExerciseCompletedNCT02014662Phase 1
- Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.CompletedNCT02014571Phase 1
- Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting ConditionsCompletedNCT02006602Phase 1
- Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting ConditionsCompletedNCT02006589Phase 1
- A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly SubjectsCompletedNCT02006537Phase 1
- Darapladib China PKCompletedNCT02000804Phase 1
- A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male SubjectsCompletedNCT02000765Phase 1
- FluLaval® Quadrivalent Pregnancy RegistryWithdrawnNCT02000466
- Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.TerminatedNCT02000453Phase 1
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of AgeCompletedNCT01999842Phase 1
- Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential ThrombocythemiaTerminatedNCT01998828Phase 2
- Study to Investigate the Irritation Potential of GSK1940029 GelCompletedNCT01984801Phase 1
- A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy SubjectsCompletedNCT01984775Phase 1
- Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.CompletedNCT01984086Phase 1
- Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002CompletedNCT01984047Phase 1
- GSK2647544 RD, DDI in Healthy Young and Elderly VolunteersTerminatedNCT01978327Phase 1
- Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid ScarsTerminatedNCT01978301Phase 1
- Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe GastroenteritisWithdrawnNCT01978223
- Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult SubjectsCompletedNCT01967771Phase 1
- A Relative Bioavailability Study of Fluticasone Furoate and LevocabastineCompletedNCT01962467Phase 1
- A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male VolunteersCompletedNCT01962454Phase 1